Gabelli Funds to Host 2nd Annual PFAS Symposium at The Harvard Club, New York, NY
GREENWICH, Conn., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Gabelli Funds, LLC, a leader in value-oriented and research-driven investment management, is excited to announce its second annual PFAS Symposium, scheduled for Thursday, September 26, 2024, at The Harvard Club in New York City. This event will bring together leading experts, policymakers, and industry executives to explore the critical issues surrounding PFAS (Per- and Polyfluoroalkyl Substances), their uses, replacements, and remediation efforts in water treatment.
The symposium will feature company presentations, fireside chats, panel discussions, and one-on-one meetings. It aims to facilitate a comprehensive dialogue on the environmental and public health challenges posed by PFAS, a class of compounds widely used in industrial and commercial applications that have raised significant concerns due to their toxicity and persistence in the environment. Prospective attendees can learn more about the symposium on our website.
Participating Companies and Key Speakers:
- 374Water (NASDAQ: SCWO) – Chris Gannon, President & CEO
- Arq, Inc. (NASDAQ: ARQ) – Bob Rasmus, CEO; Joe Wong, CTO
- Axine Water Technologies (Private) – Mark Ralph, President & CEO
- BioLargo (OTC: BLGO) – Cynthia Phillips, Advisor
- EcoBolt Water Systems (Private) – John Tavlarios, CEO
- Environmental Protection Agency (EPA) – Zach Schafer, Director of Policy & Special Projects, Office of Water
- Essential Utilities (NYSE: WTRG) – Colleen Arnold, President, Aqua
- Middlesex Water Company (NASDAQ: MSEX) – G. Christian Andreasen, VP of Engineering
- Minerals Technologies (NYSE: MTX) – Michael Kozak, VP Environmental Products; Barry Shadrix, Global Director CETCO
- National Association of Water Companies (NAWC) – Robert Powelson, President & CEO
- PermaFix (NASDAQ: PESI) – Mark Duff, President & CEO; Louis Centofanti, EVP of Strategic Initiatives
- SJW Group (NYSE: SJW) – Craig Patla, CT Water Service
- REGENESIS (Private) – Alana Miller, East Region Manager
About PFAS:
PFAS (Per- and Polyfluoroalkyl Substances) are a group of man-made chemicals that have been used in various industrial applications and consumer products since the 1940s. Known for their resistance to water, oil, and heat, PFAS have been linked to environmental and health risks, including contamination of drinking water. As these substances do not easily degrade in the environment, they have earned the nickname "forever chemicals."
About Gabelli Funds:
Gabelli Funds, LLC is a registered investment adviser with the Securities and Exchange Commission and a wholly owned subsidiary of GAMCO Investors, Inc. (OTCQX: GAMI). Gabelli Funds is renowned for its disciplined, research-driven investment process and offers a diverse array of investment products designed to meet the needs of individual and institutional investors.
The Harvard Club, New York City, NY
Thursday, September 26, 2024 starting at 8:50 am
For general inquiries or to request one-on-one meetings, contact: James Carey, Client Relations, jcarey@gabelli.com, (914) 921-8318
Contact:
Rebecca Stern
Research Analyst
(914) 921-7717
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks